CBFB and acute myeloid leukemia: Chromosomal rearrangements involving the core binding factor (CBF), including t(8;21)/RUNX1::RUNX1T1 or inv(16)/t(16;16)/CBFB::MYH11, are classified as AML‐defining alterations [2].